Germany Xenios company i-cor synchronous heart assist system is eligible for CE mark

Xenios German medical technology companies in Europe, sales of i-cor synchronous heart assist system received CE mark, i-cor system is the world's first for cardiogenic shock and high-risk interventions heartbeat synchronization heart assist system that utilizes a small of the pump to provide assistance physiological heart beat. The system can use to help sync pulse were weak heart beat, also combined with myocardial protection measures, sync pulses can cover the entire patient weak heart.
Xenios said the new system compared to traditional methods can improve a patient's heart coronary blood flow, and can limit the cardiac afterload; Executive Director of the Company Georg Matheis representation, i-cor synchronous heart assist system has been approved by the European regulatory authorities will bring a new era through development assistance in the field of percutaneous heart; we will provide each heartbeat weakened heart artificial heart, had no such direct cardiac assist method.
Now this synchronization heart assist system, unlike transdermal continuous flow system, i-cor synchronous heart assist system will be the world's first synchronized for debilitating cardiac mechanical circulatory support systems; i-cor system not only for being cardiogenic shock patients suffer provide new treatment, cardiac catheterization laboratory can also help patients at high risk of intervention; heart assist system synchronization pulse physiological overlaid or superimposed pulse attenuation patient, compared to standard therapy and is also a minimally invasive treatment.